Dermatitis - atopic and Haematemesis

Summary:

Haematemesis is found among people with Dermatitis - atopic, especially for people who are male, 2-9 old.

The study analyzes which people have Haematemesis with Dermatitis - atopic. It is created by eHealthMe based on reports of 13 people who have Dermatitis - atopic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 2,012 drugs and 1,972 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

What is Haematemesis?

Haematemesis (vomiting of blood) is found to be associated with 1,467 drugs and 2,233 conditions by eHealthMe. Check the latest studies of Haematemesis.



On Jul, 15, 2026

13 people who have Dermatitis - Atopic and Haematemesis are studied.

Would you have Haematemesis when you have Dermatitis - atopic?

Gender of people who have Dermatitis - Atopic and experienced Haematemesis *:

  • female: 30.77 %
  • male: 69.23 %

Age of people who have Dermatitis - Atopic and experienced Haematemesis *:

  • 0-1: 0.0 %
  • 2-9: 50.0 %
  • 10-19: 0.0 %
  • 20-29: 8.33 %
  • 30-39: 8.33 %
  • 40-49: 0.0 %
  • 50-59: 8.33 %
  • 60+: 25.0 %

Common co-existing conditions for these people *:

  1. Pain: 3 people, 23.08%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 15.38%
  3. Cough: 2 people, 15.38%
  4. Dry Skin: 1 person, 7.69%
  5. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 7.69%
  6. Asthma: 1 person, 7.69%
  7. Colon Cancer: 1 person, 7.69%
  8. Colorectal Cancer Recurrent (colon cancer has returned after the cure): 1 person, 7.69%
  9. Constipation: 1 person, 7.69%
  10. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 7.69%

Common drugs taken by these people *:

  1. Zofran: 5 people, 38.46%
  2. Pentamidine Isethionate: 5 people, 38.46%
  3. Diflucan: 5 people, 38.46%
  4. Flagyl: 5 people, 38.46%
  5. Fluorouracil: 5 people, 38.46%
  6. Fortaz: 5 people, 38.46%
  7. Heparin: 5 people, 38.46%
  8. Clonidine: 5 people, 38.46%
  9. Vancomycin: 5 people, 38.46%
  10. Bactrim: 5 people, 38.46%

Common symptoms for these people *:

  1. Cough: 7 people, 53.85%
  2. Diarrhea: 6 people, 46.15%
  3. Weight Decreased: 6 people, 46.15%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 46.15%
  5. Fall: 6 people, 46.15%
  6. Nausea And Vomiting: 6 people, 46.15%
  7. Gastroenteritis (inflammation of stomach and intestine): 6 people, 46.15%
  8. Nausea (feeling of having an urge to vomit): 6 people, 46.15%
  9. Gastritis (inflammation of stomach): 6 people, 46.15%
  10. Weakness: 6 people, 46.15%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haematemesis?

- Check whether Haematemesis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Haematemesis:

All the conditions that are associated with Haematemesis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haematemesis and Dermatitis - atopic, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: